Heart conditions could be treated with bear chemical

By Admin
Researchers have discovered that a chemical found in bear bile could be used to treat abnormal heart rhythms and help people to recover after a heart a...

Researchers have discovered that a chemical found in bear bile could be used to treat abnormal heart rhythms and help people to recover after a heart attack.

The ursodeoxycholic acid chemical, also known as UDCA, is traditionally used in many Chinese medicines for its ability to dissolve gallstones and reduce cholesterol levels.

However, a study conducted by academics at Imperial College London has found UDCA can also prevent potential heart attacks by stabilising dangerous and irregular heartbeats.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

UCDA works by modifying the electrical properties of myofibroblast cells, which disturb the electrical signals that control the heartbeat.

Myofibrolast cells are commonly found in the foetal heart and disappear soon after birth, emerging again in people who have had a heart attack.

Therefore, the chemical can prevent arrhythmia in the foetus as well as in heart attack patients.

Dr Julia Gorelik, one of the authors of the study, said: “These findings are exciting.

“Our results from the lab suggest that UDCA could help the heart muscle conduct electrical signals more normally.

She added: “We're hoping to set up a clinical trial to test whether these results translate to patients with heart failure.”

UDCA is already used to treat obstetric cholestasis, a condition found in pregnant women, which is linked to sudden death of the foetus.

Although UDCA is a synthesised compound, the chemical is naturally found in bear bile.

Its use in traditional medicines has received criticism from animal campaigners, who have branded its collection as cruel.

The results of the study have been published the in journal ‘Hepatology’. 

Share

Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare

Hospitals